Harrow (HROW) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -140%. A quarter ago, it was expected that this pharmaceutical and drug compounding company would post a loss of $0.25 per share when it actually produced a loss of $0.13, delivering a surprise of 48%.Over the last four quarters, t ...